Recombinant human alpha-1-antitrypsin for the treatment of inflammatory disorders

摘要

In one aspect, the disclosure relates to compositions comprising alpha-1-antitrypsin (AAT) and the production thereof. In some embodiments, the AAT is recombinantly produced. The disclosure also relates to methods of administering compositions comprising alpha-I 5 antitrypsin (AAT).